A Tale Of A Visually Impaired Reader 11/11/2010 by Intellectual Property Watch 1 Comment I’d like to introduce myself and put my personal experience in the hands of all concerned parties and people, hoping that this will help to give a better comprehension (explain) about the situation of blind people and to help reach an international treaty that will facilitate access to knowledge for people with visual impairments, writes law professor Mohammed Mohsin Abrahim El Nagaar of Alexandria University.
Panellists: Copyright Law’s ‘Byzantine Maze’ Stalling New Business Models 09/11/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments While piracy remains an oft-cited problem for the creative content industry, it is the ‘Byzantine maze’ of copyright law that is stalling monetisation of new business models better designed to deliver content in the digital age, panellists at the World Intellectual Property Organization said last week.
European Officials Eye Pan-European Passport For Collective Copyright Licencing 08/11/2010 by William New, Intellectual Property Watch Leave a Comment The European Commission is considering a proposal in the coming months to create a pan-European passport for collective music licensing intended to overcome stifling difficulties of 27 national collecting societies, a top official has told Intellectual Property Watch in the context of a meeting on copyright and competition.
US FDA’s Tough Road Ahead In Creating Pathway For Life-Saving Biologics 07/11/2010 by Liza Porteus Viana, Intellectual Property Watch Leave a Comment The US Food and Drug Administration heard from myriad pharmaceutical companies, patient groups, and other stakeholders last week as the agency considers how to create an abbreviated pathway to bring more biologic drugs to market.
Sharing US Drug Patents with Neglected Patients: A Scientist’s View 05/11/2010 by Intellectual Property Watch 1 Comment “Instead of re-hashing old debates about patents, patients and profits, forward-looking pharmaceutical executives should consider new ways of ensuring that medicines reach all patients who need them,” writes John Erickson, one of the researchers who discovered the HIV medicine recently licensed by the National Institutes of Health to the Medicines Patent Pool.
A Primer On Spotting IP Issues Associated with Social Media Websites and Content 30/10/2010 by Intellectual Property Watch Leave a Comment Most businesspeople and generalists understand that social media can be an important but risky part of doing business. This article seeks to identify how to spot potential intellectual property law issues associated with social media websites and content that can arise for a company.
Big Pharma Stranglehold: Thwarting India As Independent Maker Of Blockbuster HIV Drugs? 28/10/2010 by Intellectual Property Watch 2 Comments Daniele Dionisio writes: The current break-through of multinational drug corporations in India couples with the protectionist policies pursued by the US and EU and with India’s obligations as a WTO member. Taken together, these realities mean a heavy threat to India’s freedom as independent provider of lifesaving, affordable and state-of-the-art antiretroviral medicines to the resource-limited countries.
UN And Internet Governance, Next Four Years: Better Cooperation Or Bigger Role? 27/10/2010 by Monika Ermert for Intellectual Property Watch 2 Comments After three weeks of negotiations, member countries and the secretariat of the United Nations International Telecommunication Union hailed the consensus and success of the 2010 Plenipotentiary Conference, which sets the ITU work programme for the next four years. But even through the final rounds of applause, the tensions about how much the internet features in the core mandate of the Union remained audible.
European Ruling Could Reshape Collective Copyright Levy System 25/10/2010 by Dugie Standeford for Intellectual Property Watch Leave a Comment In a ruling expected to rock Europe’s controversial copyright levy system, the European Court of Justice held on 20 October that governments may impose fees on digital reproduction equipment to compensate rights holders only when the devices are likely to be used for private copying.
Flexibility In Government Procurement Needed For Developing Countries 22/10/2010 by Intellectual Property Watch 3 Comments If public procurement for innovation is to be seen as part of developing countries’ industrial-policy portfolio, a recent paper argues accession to the GPA would not help, and advises against it, writes Riaz K. Tayob.